India · Delayed Price · Currency is INR Intra-Cellular Therapies Statistics
Total Valuation
BOM:590030 has a market cap or net worth of INR 17.81 billion. The enterprise value is 24.22 billion.
| Market Cap | 17.81B |
| Enterprise Value | 24.22B |
Important Dates
The last earnings date was Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | Sep 12, 2024 |
Share Statistics
BOM:590030 has 203.64 million shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | 203.64M |
| Shares Outstanding | 203.64M |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | -0.44% |
| Owned by Insiders (%) | 4.89% |
| Owned by Institutions (%) | 11.93% |
| Float | 93.98M |
Valuation Ratios
The trailing PE ratio is 11.45.
| PE Ratio | 11.45 |
| Forward PE | n/a |
| PS Ratio | 0.58 |
| PB Ratio | 1.49 |
| P/TBV Ratio | 1.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.72, with an EV/FCF ratio of -8.34.
| EV / Earnings | 15.57 |
| EV / Sales | 0.78 |
| EV / EBITDA | 7.72 |
| EV / EBIT | 8.77 |
| EV / FCF | -8.34 |
Financial Position
The company has a current ratio of 1.00, with a Debt / Equity ratio of 0.60.
| Current Ratio | 1.00 |
| Quick Ratio | 0.10 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | 2.56 |
| Debt / FCF | -2.48 |
| Interest Coverage | 4.43 |
Financial Efficiency
Return on equity (ROE) is 13.68% and return on invested capital (ROIC) is 8.79%.
| Return on Equity (ROE) | 13.68% |
| Return on Assets (ROA) | 7.53% |
| Return on Invested Capital (ROIC) | 8.79% |
| Return on Capital Employed (ROCE) | 17.64% |
| Revenue Per Employee | 47.56M |
| Profits Per Employee | 2.40M |
| Employee Count | 649 |
| Asset Turnover | 1.52 |
| Inventory Turnover | 27.18 |
Taxes
In the past 12 months, BOM:590030 has paid 794.50 million in taxes.
| Income Tax | 794.50M |
| Effective Tax Rate | 33.80% |
Stock Price Statistics
The stock price has decreased by -2.24% in the last 52 weeks. The beta is 0.59, so BOM:590030's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | -2.24% |
| 50-Day Moving Average | 88.14 |
| 200-Day Moving Average | 81.08 |
| Relative Strength Index (RSI) | 43.53 |
| Average Volume (20 Days) | 249,897 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:590030 had revenue of INR 30.86 billion and earned 1.56 billion in profits. Earnings per share was 7.64.
| Revenue | 30.86B |
| Gross Profit | 7.01B |
| Operating Income | 2.44B |
| Pretax Income | 2.35B |
| Net Income | 1.56B |
| EBITDA | 2.81B |
| EBIT | 2.44B |
| Earnings Per Share (EPS) | 7.64 |
Balance Sheet
The company has 807.50 million in cash and 7.22 billion in debt, giving a net cash position of -6.41 billion or -31.48 per share.
| Cash & Cash Equivalents | 807.50M |
| Total Debt | 7.22B |
| Net Cash | -6.41B |
| Net Cash Per Share | -31.48 |
| Equity (Book Value) | 11.99B |
| Book Value Per Share | 59.11 |
| Working Capital | 27.50M |
Cash Flow
In the last 12 months, operating cash flow was -379.50 million and capital expenditures -2.53 billion, giving a free cash flow of -2.91 billion.
| Operating Cash Flow | -379.50M |
| Capital Expenditures | -2.53B |
| Free Cash Flow | -2.91B |
| FCF Per Share | -14.27 |
Margins
Gross margin is 22.72%, with operating and profit margins of 7.90% and 5.04%.
| Gross Margin | 22.72% |
| Operating Margin | 7.90% |
| Pretax Margin | 7.62% |
| Profit Margin | 5.04% |
| EBITDA Margin | 9.12% |
| EBIT Margin | 7.90% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 2.29%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 2.29% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 19.63% |
| Buyback Yield | -0.03% |
| Shareholder Yield | 2.30% |
| Earnings Yield | 8.74% |
| FCF Yield | -16.31% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |